Follow the evidence.
Proposed monitoring of trial progress, endpoints and reported results, with links to underlying sources and clear distinctions between expected and confirmed events.
Clinical trial intelligenceInstitutional life sciences intelligence
A specialist intelligence platform in development for institutional healthcare equity trading and research. Connecting clinical developments, regulatory catalysts and company pipelines.
In development · Built for institutional discoveryExplore the concept
Explore how companies, clinical assets and regulatory milestones could connect in a specialist research workflow.
Interactive demonstration · Fictional data
All names, DEMO-prefixed identifiers, assets and events are fictional. Illustrative timeframes use 20XX. No live data, investment recommendations or trading services. Watchlists last for this page visit only.
Conceptual interface only. All companies and events shown are fictional. This interactive demonstration does not provide live data, a production terminal or trading capability.
The proposed platform
Life sciences equities sit at the intersection of complex evidence and time-sensitive events. Our ambition is to bring those connections into a focused, traceable workspace that complements institutional research and trading tools.
Proposed monitoring of trial progress, endpoints and reported results, with links to underlying sources and clear distinctions between expected and confirmed events.
Clinical trial intelligenceA planned catalyst view connecting regulatory milestones to relevant companies and assets. Dates, jurisdictions and uncertainty would remain visible.
Regulatory catalyst trackingPlanned company and pipeline context to help professional users navigate assets, indications and forthcoming milestones alongside their existing analysis.
Company & pipeline insightBuilt around professional questions
We are seeking conversations with institutional market participants to understand where specialist intelligence could improve daily workflows. These audiences are our intended users, not existing customers.
Institutional brokerage, healthcare traders and sales trading teams.
Healthcare-focused hedge funds and institutional asset managers.
Biotechnology, pharmaceutical and medical technology analysts.
Healthcare research and equity markets divisions with aligned workflows.
Help shape what comes next
We welcome exploratory discussions with prospective institutional users, commercial cofounders and technology or data partners.
Institutional discovery
We are seeking conversations with professionals in healthcare equity trading, institutional brokerage, research, investment management, market data and relevant investment banking or advisory teams. Registering interest does not create an account or guarantee pilot access. Use our enquiry form to register your institutional interest.